Open access
1,361
Views
0
CrossRef citations to date
0
Altmetric
Perspective
Adapting Health Technology Assessment agency standards for surrogate outcomes in early stage cancer trials: what needs to happen?
Kristian Thorlunda Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, CanadaCorrespondence[email protected]
View further author information
, View further author information
Cal Shephardb AstraZeneca Canada, Mississauga, Ontario, CanadaView further author information
, Lisa Machadoc Canadian CML Network, Toronto, Ontario, CanadaView further author information
, Tara Bourgouind IQVIA Canada, Ottawa, Ontario, CanadaView further author information
, Lorraine Hudsonb AstraZeneca Canada, Mississauga, Ontario, CanadaView further author information
, Eon Tingb AstraZeneca Canada, Mississauga, Ontario, CanadaView further author information
, William Dempstere 3Sixty Public Affairs, Ottawa, Ontario, CanadaView further author information
& Robert Bickf The CanCertainty Coalition, Toronto, Ontario, CanadaView further author information
show all
Pages 331-342
|
Received 07 Aug 2023, Accepted 03 Jan 2024, Published online: 09 Jan 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.